These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22346438)

  • 21. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity of macrolide antibiotics in a cultured human liver cell line.
    Viluksela M; Vainio PJ; Tuominen RK
    J Antimicrob Chemother; 1996 Sep; 38(3):465-73. PubMed ID: 8889721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes Following Macrolide Use in Kidney Transplant Recipients.
    Jeong R; Quinn RR; Lentine KL; Lloyd A; Ravani P; Hemmelgarn B; Braam B; Garg AX; Wen K; Wong-Chan A; Gourishankar S; Lam NN
    Can J Kidney Health Dis; 2019; 6():2054358119830706. PubMed ID: 30815270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1867-70. PubMed ID: 9303375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs.
    Ersoy B; Aktan B; Kilic K; Sakat MS; Sipal S
    J Laryngol Otol; 2018 Jul; 132(7):579-583. PubMed ID: 29888693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae.
    Metzler K; Drlica K; Blondeau JM
    J Antimicrob Chemother; 2013 Mar; 68(3):631-5. PubMed ID: 23169894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides.
    Lan T; Rao A; Haywood J; Davis CB; Han C; Garver E; Dawson PA
    Drug Metab Dispos; 2009 Dec; 37(12):2375-82. PubMed ID: 19741038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrolide drug interactions: an update.
    Pai MP; Graci DM; Amsden GW
    Ann Pharmacother; 2000 Apr; 34(4):495-513. PubMed ID: 10772438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. History of macrolide use in pediatrics.
    Klein JO
    Pediatr Infect Dis J; 1997 Apr; 16(4):427-31. PubMed ID: 9109154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A guide to selection and appropriate use of macrolides in skin infections.
    Parsad D; Pandhi R; Dogra S
    Am J Clin Dermatol; 2003; 4(6):389-97. PubMed ID: 12762831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New macrolide antibiotics: clarithromycin and azithromycin.
    Stott GA
    Am Fam Physician; 1992 Sep; 46(3):863-9. PubMed ID: 1325106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The new macrolide antibiotics. Azithromycin and clarithromycin.
    Stein GE; Havlichek DH
    Postgrad Med; 1992 Jul; 92(1):269-72, 277-82. PubMed ID: 1319579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of macrolides and ketolides: focus on respiratory tract infections.
    Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA
    Drugs; 2001; 61(4):443-98. PubMed ID: 11324679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides.
    Gorelik E; Masarwa R; Perlman A; Rotshild V; Muszkat M; Matok I
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin.
    Aoyama T; Sunakawa K; Iwata S; Takeuchi Y; Fujii R
    J Pediatr; 1996 Nov; 129(5):761-4. PubMed ID: 8917247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.
    Dever LL; Jorgensen JH; Barbour AG
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1704-6. PubMed ID: 8215288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
    Jones RN; Doern GV; Gerlach EH; Hindler J; Erwin ME
    Diagn Microbiol Infect Dis; 1994 Apr; 18(4):243-9. PubMed ID: 7924221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.